Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

Clinical trial NCT01652872 · COMPLETED

Trial details

NCT number: NCT01652872
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia in Chronic Kidney Disease Patients Not on Dialysis

Start date: 2012-07-30
Primary completion: 2017-10-19
Enrollment: 756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.